Detecting implanted medical electrical lead dislodgement using cardiac signals

Patent metadata

Field	Value
Publication number	US-9327131-B2
Application number	US-96106510-A
Country	US
Kind code	B2
Filing date	Dec 6, 2010
Priority date	Dec 6, 2010
Publication date	May 3, 2016
Grant date	May 3, 2016

Abstract

Evaluation of an implanted electrical lead condition includes comparing electrogram template features with test electrogram features. The evaluating also includes determining the implanted electrical lead condition based solely on the electrogram comparison. The compared test electrogram features and template electrogram features may be atrial amplitudes and ventricular amplitudes. The sensing may be with a quad polar lead. The compared test electrogram features and electrogram template features may account for different patient postures and/or may account for respiration modulation.

First claim

What is claimed is:

1. A method for evaluating an implanted electrical lead condition, the method comprising:
sensing a test electrogram having test atrial cardiac potentials and test ventricular cardiac potentials using an electrode coupled to the implanted electrical lead;
comparing one or more features of an atrial template with one or more features of the test atrial potentials;
comparing one or more features of a ventricular template with one or more features of the test ventricular potentials;
comparing the one or more features of the test atrial potentials to the one or more features of the test ventricular potentials; and
determining the implanted electrical lead condition based on the comparison of the one or more features of the atrial template with one or more features of the test atrial potentials, the comparison of the one or more features of the ventricular template with one or more features of the test ventricular potentials, and the comparison of the test atrial potentials and test ventricular potentials.

2. The method of claim 1 , in which the compared test electrogram features and template electrogram features comprise atrial amplitudes and ventricular amplitudes.

3. The method of claim 2 , further comprising sensing the compared test electrogram features and electrogram template features with a quad polar lead.

4. The method of claim 2 , in which the compared test electrogram features and electrogram template features comprise features for a plurality of different patient postures.

5. The method of claim 2 , in which the compared test electrogram features and electrogram template features comprise features modulating with respiration.

6. The method of claim 1 , in which the test electrogram features and the template electrogram features comprise timing between atrial and ventricular events.

7. The method of claim 1 , in which the electrogram template features are collected when the implanted electrical lead is known to be in a correct position.

8. An implantable medical device (IMD) comprising:
an electrical lead having an electrode adapted to sense atrial cardiac potentials and to measure ventricular cardiac potentials;
a programmable microcontroller coupled to the electrical lead, the programmable microcontroller controlling operation of the IMD;
a memory coupled to the programmable microcontroller, the memory storing an atrial electrogram template and a ventricular electrogram template; and
a lead condition analysis module stored in the memory, wherein, when executed by the programmable microcontroller, the lead condition analysis module configures the IMD:
to measure a test electrogram having test atrial cardiac potentials and test ventricular cardiac potentials using the electrode;
to compare one or more features of the atrial electrogram template with one or more features of the test atrial potentials;
to compare one or more features of the ventricular electrogram template with one or more features of the test ventricular potentials;
to compare the one or more features of the test atrial potentials to the one or more features of the test ventricular potentials; and
to determine an electrical lead condition based on the comparison of the one or more features of the atrial electrogram template with one or more features of the test atrial potentials, the comparison of the one or more features of the ventricular electrogram template with one or more features of the test ventricular potentials, and the comparison of the test atrial potentials and test ventricular potentials.

9. The IMD of claim 8 , in which the compared test electrogram features and template electrogram comprise atrial amplitudes and ventricular amplitudes.

10. The IMD of claim 9 , further comprising sensing the compared test electrogram features and electrogram template with a quad polar lead.

11. The IMD of claim 9 , in which the compared test electrogram features and electrogram template comprise features for a plurality of different patient postures.

12. The IMD of claim 9 , in which the compared test electrogram features and electrogram template comprise features modulating with respiration.

13. The IMD of claim 8 , in which the test electrogram features and the template electrogram features comprise atrial morphological features and ventricular morphological features.

14. The IMD of claim 8 , in which the test electrogram features and the template electrogram features comprise timing between atrial and ventricular events.

15. A system for evaluating an implanted electrical lead condition, the system comprising:
means for measuring a test electrogram having test atrial cardiac potentials and test ventricular cardiac potentials using an electrode coupled to the implanted electrical lead;
means for comparing one or more features of an atrial electrogram template with one or more features of the test atrial potentials;
means for comparing one or more features of a ventricular electrogram template features with one or more features of the test ventricular potentials;
means for comparing the one or more features of the test atrial potentials to the one or more features of the test ventricular potentials; and
means for determining the implanted electrical lead condition based on the comparison of the one or more features of the atrial electrogram template with one or more features of the test atrial potentials, the comparison of the one or more features of the ventricular electrogram template with one or more features of the test ventricular potentials, and the comparison of the test atrial potentials and test ventricular potentials.

16. The system of claim 15 , in which the compared test electrogram features and template electrogram features comprise atrial amplitudes and ventricular amplitudes.

17. The system of claim 16 , further comprising sensing the compared test electrogram features and electrogram template features with a quad polar lead.

18. The system of claim 16 , in which the compared test electrogram features and electrogram template features comprise features for a plurality of different patient postures.

19. The system of claim 16 , in which the compared test electrogram features and electrogram template features comprise features modulating with respiration.

Assignees

• Ryu Kyungmoo
• Rosenberg Stuart
• Karst Edward
• Pacesetter Inc

Inventors

• Ryu Kyungmoo
• Rosenberg Stuart
• Karst Edward

Classifications

• A61B5/7292

  Prospective gating, i.e. predicting the occurrence of a physiological event for use as a synchronisation signal · CPC title

• A61B5/0816

  Measuring devices for examining respiratory frequency (measuring frequency of electric signals G01R23/00) · CPC title

• A61N1/3956

  Implantable devices for applying electric shocks to the heart, e.g. for cardioversion · CPC title

• A61N1/37 Primary

  Monitoring; Protecting · CPC title

• A61B2560/0276

  Determining malfunction · CPC title